The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Praxair's revenues will increase 1.8% and EPS will contract 0.0%.
The average estimate for revenue is $2.89 billion. On the bottom line, the average EPS estimate is $1.38.
Last quarter, Praxair booked revenue of $2.80 billion. GAAP reported sales were 0.1% higher than the prior-year quarter's $2.80 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $1.38. GAAP EPS of $1.38 were the same as the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 43.4%, 60 basis points better than the prior-year quarter. Operating margin was 19.1%, 180 basis points worse than the prior-year quarter. Net margin was 14.8%, 20 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $12.02 billion. The average EPS estimate is $6.01.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 667 members out of 693 rating the stock outperform, and 26 members rating it underperform. Among 148 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 145 give Praxair a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Praxair is outperform, with an average price target of $116.32.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Praxair. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Praxair to My Watchlist.